LISA REHBERGER: Open Payments
NPI 1255674917 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,633 in 99 payments from 14 companies in 2025. Trend: 2023 $694 · 2024 $1,019 · 2025 $1,633
Food & beverage: $1,633
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $425 |
| Janssen Biotech, Inc. | 24 | $369 |
| Lilly USA, LLC | 4 | $148 |
| Organon LLC | 12 | $117 |
| Novartis Pharmaceuticals Corporation | 5 | $101 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $77 |
| Regeneron Healthcare Solutions, Inc. | 4 | $71 |
| Incyte Corporation | 4 | $68 |
| GENZYME CORPORATION | 3 | $65 |
| Galderma Laboratories, L.P. | 1 | $62 |
Products named: TREMFYA, RINVOQ, SKYRIZI, EBGLYSS, DUPIXENT, ILUMYA, COSENTYX, HADLIMA.
Industry payments across WA — which companies pay providers there.
